EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOMEG00000001386
Gene Symbol: ERBB4
1 Cross references
47 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4a

Ensembl ID : ENSOMEG00000013241
Gene Symbol: ERBB4A
1 Cross references
230 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOMEG00000009991
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSOMEG00000005049
Gene Symbol: LOC112142788
3 Cross references
208 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSOMEG00000023615
Gene Symbol: LOC112158498
3 Cross references
198 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSOMEG00000011460
Gene Symbol: ESRRGA
1 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOMEG00000007343
Gene Symbol: XPO1
1 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOMEG00000001384
Gene Symbol: XPO1
3 Cross references
213 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSOMEG00000008297
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSOMEG00000020947
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSOMEG00000016411
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSOMEG00000004559
Gene Symbol: LOC112162937
2 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).